|
|
||||||||
ORIGINAL RESEARCH COMMUNICATIONS |
1 From the Department of Zoology, University of Oxford, Oxford, United Kingdom (FM); the Center for Veterinary Medicine, Food and Drug Administration, Laurel, MD (LY); and the Division of Public Health and Primary Health Care, University of Oxford, Institute of Health Sciences, Oxford, United Kingdom (AN).
2 Supported by the UK Department of Health and The Sir Jules Thorn Charitable Trust. FM is a Royal Society Research Fellow. 3 Address reprint requests to F Mathews, Department of Zoology, South Parks Road, Oxford OX1 3PS, United Kingdom. E-mail: fiona.mathews{at}zoology.ox.ac.uk..
| ABSTRACT |
|---|
|
|
|---|
Objective: The objective was to examine the relations between indexes of maternal nutritional status in pregnancy and the birth and placental weights of infants born at term.
Design: We conducted a prospective cohort study of 798 white nulliparous women with singleton pregnancies. Blood samples were obtained at
16 and 28 wk of gestation.
Results: The concentration of most nutrients was not associated with pregnancy outcome. High retinol and hemoglobin concentrations in late, but not in early, pregnancy were strongly and independently associated with lower birth weight and smaller placental size at birth. Each 0.1-µmol increase in retinol predicted a 20.8-g (95% CI: 9.2, 32.5 g) decrease in birth weight (P < 0.001), and each 0.1-g/L increase in hemoglobin predicted a 61.5-g (95% CI: 28.5, 94.4 g) decrease in birth weight (P < 0.001).
Conclusions: We found negative associations between birth and placental weights and maternal retinol and hemoglobin concentrations. These relations may be causal or may reflect an underlying metabolic dysfunction, such as failure of plasma volume expansion. Our results provide no evidence that having high circulating nutrient concentrations, for example, through the use of supplements, would improve infant and placental growth.
Key Words: Pregnancy nutrition birth weight placenta smoking human
| INTRODUCTION |
|---|
|
|
|---|
| SUBJECTS AND METHODS |
|---|
|
|
|---|
Blood samples for nutritional analyses and hematology were obtained from subjects at
16 wk of gestation, or "early pregnancy." The samples were taken during routine venipuncture for "triple test" genetic abnormality screening (the triple test measures
-fetoprotein, human chorionic gonadotropin, and estriol concentrations), which screens for Down Syndrome and neural tube defects. A second blood sample was obtained at
28 wk of gestation, or "later pregnancy." Samples were collected into plain evacuated tubes and refrigerated immediately. The serum was stored at -70°C within 3 h of collection for samples taken at booking clinics. Blood samples taken later in gestation were processed within 24 h of collection; the delay was due to the need for blood to arrive from outlying midwives' clinics. Blood samples for routine hematology tests were collected into evacuated tubes containing EDTA. In addition to blood indexes of nutritional status, dietary intake was assessed as described elsewhere (3, 5). The main method of dietary assessment was a 7-d semiquantitative food diary kept in the week after booking, with detailed instruction and support being provided by trained personnel. The usual diet thereafter was reported in a food-frequency questionnaire mailed at 28 wk of gestation.
Infants were weighed at delivery to the nearest 5 g on digital scales (Seca 757; Seca Ltd, Birmingham, United Kingdom). Placentas were weighed to the nearest 1 g on digital scales (Soehnle Quanta; Soehnle-Waagen GmbH & Co, Murrhardt, Germany). All scales were checked weekly against standard metal weights and were calibrated if necessary. A standardized method was used to prepare the placentas for weighing: the amnion was stripped to the cord, the chorion was cut at the edge of the placenta, and the cord was removed flush with the placenta. Data on obstetric history and maternal anthropometric measurements were abstracted from the mother's hospital records after delivery. Gestational age at delivery (in days) was based on the date of the last menstrual period (LMP). However, ultrasound scan dates were used if the LMP date was unknown (n = 19) or if a scan taken at < 20 wk gave a gestational age that differed by > 14 d from that given by the LMP date (n = 70). Pediatric assessment of maturity at delivery was accepted if it differed by > 28 d from that calculated from the LMP date or ultrasound (n = 3). No gestational age estimates were missing.
Laboratory investigations
Serum ferritin and vitamin B-12 were measured with the use of a microparticle enzyme immunoassay (Abbott Laboratories, Chicago) and folate was measured with an ion capture assay (Abbott Laboratories) at the Reference Hematology Laboratory, John Radcliffe Hospital, Oxford, United Kingdom. The laboratory subscribes to the UK National External Quality Assessment Scheme. Selenium was measured in duplicate (mean used in analysis) by inductively coupled serum mass spectrometry at the SAS Trace Element Unit, Southampton General Hospital, United Kingdom (9, 10). The laboratory participates in 2 external quality-assessment schemes and performed the selenium assays for the National Diet and Nutrition Surveys (11). Lipid-soluble antioxidant assays were conducted with the use of HPLC at the Imperial Cancer Research Fund Clinical Trials Service Unit, Oxford, United Kingdom. Samples taken at different time points from the same individual were analyzed simultaneously to reduce analytic variability. Total serum cholesterol was measured with an enzymatic colorimetric method (MPR2 CHOD-PAP kit with Preciset Cholesterol Standard; Boehringer Mannheim, Lewes, United Kingdom) at the Diabetes Research Laboratories, Radcliffe Infirmary, Oxford, United Kingdom. The intraassay CVs for the assays were as follows: folate, 2.28.3%; ferritin, 1.84.9%; vitamin B-12, 3.94.5%; selenium, < 10%; cholesterol, < 2.0%; and lipid-soluble vitamins, 4.66.7%. The corresponding interassay CVs were as follows: folate, 2.29.3%; ferritin, 3.36.2%; vitamin B-12, 6.48.5%; selenium, 3.17.8%; cholesterol, < 2%; and lipid-soluble vitamins, 6.711.8%. Routine hematologic measurements were performed as part of the subject's standard antenatal care at St Mary's Hospital Portsmouth, which subscribes to the UK National External Quality Assessment Scheme. Blood counts were made with the use of a Coulter counter (Coulter Electronics Ltd, Luton, United Kingdom). Serum cotinine concentrations were measured with a radioimmunoassay, as described elsewhere (12, 13).
It was not possible in all cases to obtain sufficient blood for the full range of analyses, as indicated in the results. In addition, serum ferritin and vitamin B-12 were measured only in those women whose routine hematologic data were available. Some samples were not analyzed for technical reasons (principally sample hemolysis).
Data analysis
We used SPSS for WINDOWS (version 10.0; Chicago) to analyze the data. Tests of significance were two-tailed. P < 0.05 was considered statistically significant, but because of the large number of tests conducted, we interpreted P values cautiously throughout and considered values < 0.05 but > 0.01 as marginal. After a preliminary univariate analyses, the data were examined by using multiple linear regression. The fit of models was ascertained by an examination of residuals. Each model was built by using a combination of forced entry and forward stepwise procedures: where the latter was used, the criterion for entry was P < 0.05 and for removal P > 0.10. To avoid instability in the models, only cases with valid data for all of the variables in that particular analysis (no missing values) were included.
Over the ranges studied, placental and birth weights showed linear relations with gestational age and were also associated with sex. For clarity, and for comparison with other studies, the residuals between the observed measurements and those predicted by linear regression were computed. These residuals were then added to the mean for the cohort. The measures presented are therefore individually adjusted to the mean gestational age and sex of the cohort. Placental weights were loge transformed to satisfy the assumptions of normality. The relations of placental and birth weights to maternal factors (including nutritional status), sex of the infant, and gestational age were examined with analyses prespecified in the protocol as described below. To reduce the number of possible exposure variables tested, the only dietary variable included in the current analyses was vitamin C, which we had previously found to be the only nutritional variable associated with either placental or birth weight (3).
The following covariates were examined as previously described (3): sex of infant (male, female), smoking status (0 = nonsmoker, 1 = smoker), number of cigarettes smoked on the day before the interview (0 and approximately equal groups: 18, 916, and
17), maternal age at first hospital visit (days), reported preconceptional weight (kg), maternal weight (kg) at first hospital visit, maternal height (m), body mass index (BMI; in kg/m2) before conception, BMI at first hospital visit (
16 wk of gestation), diastolic blood pressure at first hospital visit, hemoglobin concentration at first hospital visit (g/L), social class in 3 groups (I and II, IIINM and IIIM, and IV and V, where I is the highest class), and education in 3 groups (higher than ordinary-level school-leaving examination or equivalent, ordinary level, and lower than ordinary level). Women were classified as smokers if they reported smoking or if their serum cotinine concentration was > 14 µg/L (14). Full details are given elsewhere (12, 13).
| RESULTS |
|---|
|
|
|---|
16 wk of gestation, and this group did not differ significantly by age or social class from the rest of the cohort. For comparison with other studies, the 51 subjects with preterm deliveries (< 259 d gestation) were excluded, which gave a sample size of 798 for our primary analyses. Food diaries had been completed by 650 (81%) of these women (data presented previously; 3). A third-trimester blood sample was available for 641 (80%) of the women. For clarity, data were excluded from the 39 women with term deliveries who had provided a blood sample in the third, but not in the second, trimester; the failure to obtain a sample was due to an oversight by the midwife or to a collapsed vein during sampling. A flow chart of subject participation in the study is shown in Figure 1
|
|
|
|
The changes in hemoglobin and retinol concentrations during pregnancy were also predictors of birth weight (P < 0.001 and P = 0.002, respectively, after adjustment for smoking and height): the larger the decrease as pregnancy progressed, the bigger the infant. No other change in nutrient concentration was significantly associated with birth weight. In neither early nor later pregnancy were there any significant interactions between maternal smoking and nutrient status.
Data on both retinol and hemoglobin were available for 558 women. In multiple linear regression analysis, which also included maternal smoking and height, each of these variables was independently predictive of birth weight after adjustment for the other (retinol: partial R2 = 0.016, P = 0.002; hemoglobin: partial R2 = 0.020, P = 0.001). Intake of vitamin C was the only dietary factor found in our previous analysis to be an independent predictor of birth weight (3). It remained a significant predictor, and the results for the other variables were unchanged, when it was entered into a simultaneous regression analysis (Table 4
). Overall, the model explained 37% (adjusted R2) of the variability in raw birth weights.
|
11% (Table 5
-Carotene, cholesterol, and ferritin in early pregnancy were all also associated with placental weight, but these relations were marginal (P > = 0.02 in each case) and did not remain significant after adjustment for selenium concentrations. As for birth weight, vitamin C intake had previously been found to be the only dietary variable associated with placental size (3). The relations of both selenium and vitamin C to placental weight were essentially unchanged when they were regressed simultaneously (P = 0.029 and 0.016, respectively; n = 493).
|
Data on both retinol and hemoglobin in later pregnancy, together with a trimmed placental weight, were available from 516 women. In simultaneous regression analysis, retinol, hemoglobin, and maternal height were all independently predictive of loge placental weight. These relations were unchanged by the addition of dietary vitamin C into the model (Table 6
). However, it is important to note that overall, maternal height, retinol, hemoglobin, dietary vitamin C, infant gestational age, and sex accounted for only 11% of the variability in placental weights.
|
| DISCUSSION |
|---|
|
|
|---|
The study had a large sample size and a prospective design. One of the strengths of the cohort is that it is similar, in terms of both smoking status and socioeconomic class, to nationally representative samples of pregnant women in the United Kingdom (6, 7, 15). The study is unusual in that it collected data on a wide range of nutrients and considered both dietary intake and circulating nutrient concentrations as indexes of exposure. Care was taken to assess potential confounding variables accurately, and smoking status was validated on the basis of serum cotinine. The inclusion of only nulliparous women avoids the major confounding effect of parity, which contributes to both pregnancy outcome and health behaviors.
The main weakness of the study, as with any observational design, is the possibility that unknown confounding factors were not adjusted for. It was also not possible to investigate every nutrient: recent work suggests that n-3 fatty acids prolong gestation and increase birth weight, for example (16, 17). Finally, the relations observed between nutrition and pregnancy outcome may differ in extreme circumstances (such as in starvation or in animal experiments). Nevertheless, the issue of whether maternal nutritional status does affect pregnancy outcome in women from industrialized countries is of great clinical and public health importance and must be distinguished from that of whether such effects can be produced (18).
Debate surrounds the use of both retinol and iron supplements during pregnancy. High doses of retinol are teratogenic, and in some countries pregnant women are advised to avoid retinol-containing supplements and liver (19). However, this advice may lead to vitamin A deficiency (20). Retinol is important in cell differentiation and growth (21). We had therefore hypothesized that low serum retinol is associated with reduced fetal size, but our data suggest the opposite relation. In the only other study of this nutrient, no association was found between plasma retinol and birth weight in a sample of 423 American women (22).
Serum retinol is a relatively insensitive indicator of body vitamin A status. Only 1% of the body's reserves circulate in the serum, and homeostatic mechanisms control concentrations via retinol binding protein concentrations. It is therefore not surprising that we found no associations between dietary vitamin A and birth and placental weights (3). In contrast, fetuses have limited control over their retinol concentrations. They have low liver stores and do not synthesize retinol binding protein until late in gestation (23). Small differences in maternal serum retinol concentrations may therefore be important for the fetus.
Alternatively, the negative relation between serum retinol in later pregnancy and fetal growth may not be causal but reflects some underlying metabolic disturbance. Placental blood flow is critically important to fetal growth (24). The delivery of many hormones and metabolites to the fetus depends both on maternal concentrations and placental perfusion rates. Thus, maternal nutrient concentrations could be high, yet delivery to the fetus low, if there is poor placental blood flow. Plasma volume expansion is one of the prime mechanisms for maintaining blood flow in pregnancy. Low plasma volume expansion is associated with poor fetal growth (25), and it could also curb the normal decrease in plasma nutrient concentrations during pregnancy. Our finding that the mothers of lighter infants had smaller reductions in retinol concentrations during pregnancy supports this hypothesis. Alternatively, retinol concentrations may directly influence placental blood flow and, hence, indirectly affect placental and fetal growth. This pathway has been noted in rats: protein-energy malnutrition lowered placental and fetal growth via reduced placental blood flow (26).
A mechanism involving blood flow may also explain the results for hemoglobin. As did retinol, hemoglobin had inverse relations with infant and placental size that were apparent in later, but not in early, pregnancy. Inverse relations of hemoglobin to placental and infant size, as well as a U-shaped relation, have been reported (27-30). Hemoglobin concentrations only weakly reflect nutritional status in developed countries but are strongly influenced by plasma volume, especially in later pregnancy. At high hemoglobin concentrations, blood becomes more viscous and the efficiency of placental perfusion is reduced. Additionally, low flow rates themselves reinforce increased blood viscosity (31). One small study found that after accounting for the effects of plasma volume, the relation with birth weight disappears (31). PCV, like hemoglobin, is also influenced by plasma volume. The highly significant negative relation we found between PCV and birth and placental weights concords with several other cohort studies (31-35) and supports our blood flow hypothesis. We used ferritin as an index of iron stores: the lack of convincing associations with pregnancy outcome again suggests that the associations for hemoglobin were not primarily nutritional in origin.
Most of the other nutrients we investigated have a much stronger relation to short-term dietary intake than do retinol, hemoglobin, or ferritin (36). We therefore expect them to have a weaker relation with plasma volume, because of day-to-day variation. The imprecision of snapshot measurements may explain why there were no significant negative associations between most other nutrients and birth or placental weights, although many showed negative trends.
It is notable that retinol and hemoglobin concentrations are associated with placental weight and with birth weight. The finding that placental and birth weights are causally related strengthens our interpretation that the associations are real. Our results do not suggest that higher maternal circulating concentrations of nutrients improve fetal and placental growth among the relatively well nourished women of industrialized countries. Rather, the opposite relation was observed. Although this association may not be causal, caution should be exercised in the use of supplements containing retinol until further evidence is available. Similarly, a routine reversal of normal declines in hemoglobin in well-nourished women seems unwise, particularly because high hematocrit and hemoglobin values (35) and routine supplementation (37) are associated with low birth weight and preterm delivery. The vast majority of the variance in placental and infant weights remains unexplained, and resources should be directed toward investigating other determinants. We conclude that the maternal intake of the nutrients measured is unlikely to be an important determinant of the long-term health of infants.
| ACKNOWLEDGMENTS |
|---|
FM had the original idea for the study. FM and AN devised the research questions, formulated the study design, and obtained funding. FM collected the data, performed the statistical analysis, wrote the first draft of the paper, and is the manuscript's guarantor. LY provided advice on the biochemical assays of nutritional status and supervised the assays of the lipid-soluble vitamins when she was based at the Imperial Cancer Research Fund Clinical Trials Service Unit, Oxford, United Kingdom. All 3 authors contributed to the preparation of the manuscript. None of the authors had any financial or personal interest in any company or organization sponsoring the research and had no advisory board affiliations.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
E. T Masters, W. Jedrychowski, R. L Schleicher, W.-Y. Tsai, Y.-H. Tu, D. Camann, D. Tang, and F. P Perera Relation between prenatal lipid-soluble micronutrient status, environmental pollutant exposure, and birth outcomes Am. J. Clinical Nutrition, October 1, 2007; 86(4): 1139 - 1145. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M Bodnar and M. C Nelson Maternal nutrition and fetal growth: bias introduced because of an inappropriate statistical modeling strategy may explain null findings Am. J. Clinical Nutrition, August 1, 2004; 80(2): 525 - 526. [Full Text] [PDF] |
||||
![]() |
F. Mathews, L. Youngman, and A. Neil Reply to LM Bodnar and MC Nelson Am. J. Clinical Nutrition, August 1, 2004; 80(2): 526 - 527. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |